Skip to main content
. 2018 Aug 21;16(5):5891–5899. doi: 10.3892/ol.2018.9338

Table II.

Inhibitory effect of PPD12 on major CYP metabolic activities in human liver microsomes.

IC50 (µM)

CYP enzyme Catalysis Inhibitor Inhibitor PPD12
3A4 Midazolam 1′-hydroxylation Ketoconazole 0.0040 1.03
3A4 Testosterone 6-β-hydroxylation Ketoconazole 0.0154 8.43
1A2 Phenacetin 0-deethylation α-Naphthoflavone 0.0168 >33
2B6 Bupropion hydroxylation Ticlopidine 0.0823 2.21
2C8 Amodiaquine N-deethylation Quercetin 0.7319 9.57
2C9 Diclofenac4′-hydroxylation Sulfaphenazole 0.0856 >33
2C19 S-mephenytoin4′-hydroxylation Ticlopidine 0.5120 15.04
2D6 Dextromethorphandextrorphan Quinidine 0.0235 11.85

PPD12, 20(S)-protopanaxadiol derivative; CYP, cytochrome P450.